Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
DataCT Selected as Independent Administrator of the U.S. Consolidated Tape Plan
-
Boot Barn Opens at Marketplace at Seminole Towne Center
-
Quantify Funds to Close STKd ETFs APED, SPCY, and ZIPP
-
Defiance ETFs Announces Closure of JPX, XPM, and VIXI Funds
-
Enerpac Tool Group Reports First Quarter Fiscal 2026 Results
-
NFI Announces CEO Transition
-
Capital Power Announces Conversion Results for Its Preferred Shares (Series 1)
-
CISO Global Books Over $1.1M in CHECKLIGHT® Software Sales -
-
Rivalry Reports Record Ontario Performance
-
Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders
-
Village Farms International Creates Global Strategy Officer Role and Appoints Brian Stevenson
-
Winnebago Industries Board of Directors names John Murabito as chair; Declares quarterly cash dividend
-
Guardforce AI Announces Receipt of Nasdaq Minimum Bid Price Deficiency Notification Letter
-
Nevada Titan Project Exploration Update, Magnetic Survey Confirmation – 8 Targets Identified.
-
Boumarang, Inc. Files S-1 Registration Statement with the U.S. Securities and Exchange Commission
-
CVB Financial Corp. and Heritage Commerce Corp Announce Agreement to Merge
-
OFA Group Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
-
Voting Rights and Shares Capital of the Company
-
BRT Apartments Corp. Completes Debt Refinancings
-
CancerVax Reports Nanoparticle Component Success in Preparation for Animal Studies
-
Methode Electronics’ Board Approves Dividend
-
Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
Great Southern Bancorp, Inc. announces quarterly dividend of $0.43 per common share
-
Hudson Technologies Announces Accretive Acquisition of Refrigerants Inc.
-
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
-
Immuneering Advances Towards Dosing First Patient in Phase 3 Atebimetinib Trial for First-Line Metastatic Pancreatic Cancer Patients, Securing Alignment with FDA and EMA
-
Parks! America Authorizes Share Repurchase Program
-
Haoxin Holdings Limited Receives Nasdaq Notification Regarding Minimum Bid-Price Requirement
-
Brompton Funds Declare Distributions and Special Year End Distributions
-
Kalaris Therapeutics Reports Positive Initial Phase 1a Data for TH103 in Treatment-Naïve Neovascular AMD
-
VITEC and Actelis Networks Announce Partnership to Bring IPTV to RF-Only Facilities
-
Micron Technology, Inc. Reports Results for the First Quarter of Fiscal 2026
-
VITEC and Actelis Networks Announce Partnership to Bring IPTV to RF-Only Facilities
-
Inventiva to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Crane Harbor Acquisition Corp. II Completes Upsized $345 Million Initial Public Offering
-
Xcel Brands Announces $2.05 Million Private Placement
-
Spartan Capital Releases Its Highly Anticipated 2026 Economic Outlook
-
2026 NAB Show Registration Opens with First Look at Major Program Enhancements
-
Crest and Balise Appoint Mike Mercer Vice President of Sales & Marketing
-
Crest and Balise Appoint Mike Mercer Vice President of Sales & Marketing
-
Fredonia Mining Inc. Announces Intention to Amend Price of Previously Issued Warrants and Implement Early Warrant Exercise Incentive Program
-
SSRG Acquires Pillar Security, Expanding Ontario Footprint
-
The National Civil Rights Museum Announces King Day 2026 Celebration
-
Yukon Metals Announces CEO Transition
-
New Ebook Offers First-Time Biotech CEOs a Roadmap for the Decisions That Determine Company Success
-
BDC introduces platform to provide $4B to boost Canada’s defence and security ecosystem
-
Holiday Host Stress Drives More Call-Outs Than Christmas Disasters, Says New Fantastic Cleaners Holiday Report
-
Gen Alpha steps into the C-Suite: Gabb’s new council puts kids in charge
-
SBM Offshore signs contract extension of FPSOs Mondo and Saxi Batuque
-
Levin Papantonio - Federal Court Creates New MDL for Ozempic and Other GLP-1 Drugs Linked to Vision Loss (NAION)

